<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Myeloma Beacon &#187; Treatments</title>
	<atom:link href="http://www.myelomabeacon.com/category/links/treatments/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.myelomabeacon.com</link>
	<description>Multiple myeloma news, resources, and online forums for patients, caregivers, and others interested in multiple myeloma.</description>
	<lastBuildDate>Fri, 10 Feb 2012 06:37:57 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	
		<item>
		<title>Prednisone.com: The official site for prednisone information</title>
		<link>http://www.myelomabeacon.com/links/2008/10/15/prednisonecom-the-official-site-for-prednisone-information/</link>
		<comments>http://www.myelomabeacon.com/links/2008/10/15/prednisonecom-the-official-site-for-prednisone-information/#comments</comments>
		<pubDate>Wed, 15 Oct 2008 12:00:00 +0000</pubDate>
		<dc:creator>The Myeloma Beacon Staff</dc:creator>
				<category><![CDATA[Links]]></category>
		<category><![CDATA[Treatments]]></category>

		<guid isPermaLink="false">http://www.myelomabeacon.com/?p=1059</guid>
		<description><![CDATA[<p>Prednisone is a synthetic corticosteroid drug which is usually taken orally and can be used for a large number of different conditions. It has a mainly glucocorticoid effect. Prednisone is a &#8220;prodrug&#8221; that is converted by the liver into prednisolone,&#8230;</p>]]></description>
			<content:encoded><![CDATA[<p>Prednisone is a synthetic corticosteroid drug which is usually taken orally and can be used for a large number of different conditions. It has a mainly glucocorticoid effect. Prednisone is a &#8220;prodrug&#8221; that is converted by the liver into prednisolone, which is the active drug and a steroid.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.myelomabeacon.com/links/2008/10/15/prednisonecom-the-official-site-for-prednisone-information/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Zometa.com: Zometa (zoledronic acid) Therapy and Multiple Myeloma</title>
		<link>http://www.myelomabeacon.com/links/2008/10/15/zometacom-zometa-zoledronic-acid-therapy-and-multiple-myeloma/</link>
		<comments>http://www.myelomabeacon.com/links/2008/10/15/zometacom-zometa-zoledronic-acid-therapy-and-multiple-myeloma/#comments</comments>
		<pubDate>Wed, 15 Oct 2008 12:00:00 +0000</pubDate>
		<dc:creator>The Myeloma Beacon Staff</dc:creator>
				<category><![CDATA[Links]]></category>
		<category><![CDATA[Treatments]]></category>

		<guid isPermaLink="false">http://www.myelomabeacon.com/?p=1060</guid>
		<description><![CDATA[<p>ZOMETA is a treatment for multiple myeloma that may reduce or delay bone problems‚ such as fractures that can result from bone damage. ZOMETA can also help patients who already have experienced bone complications. ZOMETA is not chemotherapy and may&#8230;</p>]]></description>
			<content:encoded><![CDATA[<p>ZOMETA is a treatment for multiple myeloma that may reduce or delay bone problems‚ such as fractures that can result from bone damage. ZOMETA can also help patients who already have experienced bone complications. ZOMETA is not chemotherapy and may be used with other cancer treatments‚ such as radiation‚ hormonal therapy‚ or chemotherapy.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.myelomabeacon.com/links/2008/10/15/zometacom-zometa-zoledronic-acid-therapy-and-multiple-myeloma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Revlimid.com: Information for Patients and Health Care Providers</title>
		<link>http://www.myelomabeacon.com/links/2008/10/15/revlimidcom-information-for-patients-and-healthcare-providers/</link>
		<comments>http://www.myelomabeacon.com/links/2008/10/15/revlimidcom-information-for-patients-and-healthcare-providers/#comments</comments>
		<pubDate>Wed, 15 Oct 2008 12:00:00 +0000</pubDate>
		<dc:creator>The Myeloma Beacon Staff</dc:creator>
				<category><![CDATA[Links]]></category>
		<category><![CDATA[Treatments]]></category>

		<guid isPermaLink="false">http://www.myelomabeacon.com/?p=1061</guid>
		<description><![CDATA[<p>REVLIMID® (lenalidomide) in combination with dexamethasone is indicated for the treatment of multiple myeloma patients who have received at least one prior therapy.</p>
]]></description>
			<content:encoded><![CDATA[<p>REVLIMID® (lenalidomide) in combination with dexamethasone is indicated for the treatment of multiple myeloma patients who have received at least one prior therapy.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.myelomabeacon.com/links/2008/10/15/revlimidcom-information-for-patients-and-healthcare-providers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Velcade.com: The offical site for Velcade (bortezomib)</title>
		<link>http://www.myelomabeacon.com/links/2008/10/15/velcadecom-the-offical-site-for-velcade-bortezomib/</link>
		<comments>http://www.myelomabeacon.com/links/2008/10/15/velcadecom-the-offical-site-for-velcade-bortezomib/#comments</comments>
		<pubDate>Wed, 15 Oct 2008 12:00:00 +0000</pubDate>
		<dc:creator>The Myeloma Beacon Staff</dc:creator>
				<category><![CDATA[Links]]></category>
		<category><![CDATA[Treatments]]></category>

		<guid isPermaLink="false">http://www.myelomabeacon.com/?p=1071</guid>
		<description><![CDATA[<p>VELCADE® (bortezomib) for Injection is indicated for the treatment of patients with multiple myeloma.  VELCADE is contraindicated in patients with hypersensitivity to bortezomib, boron, or mannitol.</p>
]]></description>
			<content:encoded><![CDATA[<p>VELCADE® (bortezomib) for Injection is indicated for the treatment of patients with multiple myeloma.  VELCADE is contraindicated in patients with hypersensitivity to bortezomib, boron, or mannitol.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.myelomabeacon.com/links/2008/10/15/velcadecom-the-offical-site-for-velcade-bortezomib/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Thalomid.com: The official site for Thalomid (thalidomide)</title>
		<link>http://www.myelomabeacon.com/links/2008/10/15/thalomidcom-the-official-site-for-thalomid-thalidomide/</link>
		<comments>http://www.myelomabeacon.com/links/2008/10/15/thalomidcom-the-official-site-for-thalomid-thalidomide/#comments</comments>
		<pubDate>Wed, 15 Oct 2008 12:00:00 +0000</pubDate>
		<dc:creator>The Myeloma Beacon Staff</dc:creator>
				<category><![CDATA[Links]]></category>
		<category><![CDATA[Treatments]]></category>

		<guid isPermaLink="false">http://www.myelomabeacon.com/?p=1072</guid>
		<description><![CDATA[<p>THALOMID® (thalidomide) in combination with dexamethasone is indicated for the treatment of patients with newly diagnosed multiple myeloma.</p>
]]></description>
			<content:encoded><![CDATA[<p>THALOMID® (thalidomide) in combination with dexamethasone is indicated for the treatment of patients with newly diagnosed multiple myeloma.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.myelomabeacon.com/links/2008/10/15/thalomidcom-the-official-site-for-thalomid-thalidomide/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

